178
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Stabilization of Rasburicase and Physico‐Chemical Characterization of the Resulting Injectable Formulation

, , , , , , , & show all
Pages 877-889 | Published online: 24 Sep 2004

References

  • Geigert J. Overview of the stability and handling of recombinant protein drugs. J. Parent. Sci. Technol. 1989; 43(5)220–224
  • Pikal M. J. Freeze—Drying of Proteins, Part II : Formulation Selection Biopharm. October, 1990; 26–30
  • Pui C. H., Sima J., Camita B. (2000) Blood, Meeting Info. 42nd Annual meeting of the America Society of Hematology, San FranciscoCA, USA, December, 01–052000. American Society of Hematology, 11–96, Part I, pp719a. print
  • Pui C. H., Mahmoud H. H., Wiley J. M., Woods G. M., Leverger G., Camitta B., Hastings C., Blaney S., Relling M. V., Reaman G. H. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J. Clin. Oncol. 2000; 19(3)697–704
  • Colloc'h N., El Hajji M., Bachet B., Lhermite G., Schiltz M., Prange T., Castro B., Mornon J. P. Crystal structure of the protein drug urate oxidase—inhibitor complex at 2.05 Å resolution. Nat. Struct. Biol. 1997; 4: 947–952, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Legoux R., Delpech B., Dumont X., Guillemot J. C., Ramond P., Shire D., Caput D., Ferrara P., Loison G. Cloning and expression in Escherichia coli of the gene encoding Aspergillus flavus urate oxidase. J. Biol. Chem. 1992; 267(12)8565–8570, [PUBMED], [INFOTRIEVE]
  • Leplatois P., Le Douarin B., Loison G. High‐level of a peroxisomal enzyme: Aspergillus flavus uricase accumulates intracellularly and is active in Saccharomyces cerevisiae. Gene 1992; 122: 139–145, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Bayol A., Dupin P., Boe J. F., Claudy P., Letoffe J. M. Study of pH and temperature—induced transitions in urate oxidase (Uox‐EC 1.7.3.3.) by microcalorimetry (DSC), size exclusion chromatography (SEC) and enzymatic activity experiments. Biophys. Chemist. 1995; 54: 229–235, [CROSSREF]
  • Boutonnet‐Fagegaltier N., Ménégotto J., Lamure A., Duplaa H., Caron A., Lacabanne C., Bauer M. Molecular mobility study of amorphous and crystalline phases of a pharmaceutical product by thermally stimulated current spectroscopy. J. Pharm. Sci. 2002; 91(6)1548–1560, [CROSSREF]
  • Menegotto J., Demont P., Bernes A., Lacabanne C. Combined dielectric spectroscopy and thermally stimulated currents studies of secondary relaxation process in amorphous Poly(ethylene terephthalate). J. Polym. Sci., Part B, Polym. Phys. 1999; 37: 3494–3503
  • Menegotto J., Demont P., Lacabanne C. Secondary dielectric dielectric‐relaxation in amorphous poly(ethylene terephthalate): combined thermally stimulated and isothermal depolarization current investigations. Polymer 2001; 42: 4375–4383, [CROSSREF]
  • Lacabanne C., Lamure A., Teyssedre G., Bernes A., Mourgues M. Study of cooperative relaxation modes in complex systems by thermally stimulated current spectroscopy. J. Non‐Cryst. Solids 1994; 172–174: 884–890, [CROSSREF]
  • Bayol A., Breul T., Dupin P., Faure P. Stable Freeze‐Dried Formulation Comprising a Protein Assay kit. Patent, EP0682944B1 1999/US serial no. 5,763,409, 1998
  • Yu‐Chang J. W., Hanson M. A. Parenteral formulations of proteins and peptides: stability and stabilizers (1988). J. Parent. Sci. Technol. 1988; 10(Supp.)42‐S4‐S26, Technical Report N°
  • Bayol A., Capdevielle J., Malazzi P., Buzy A., Bonnet M. C., Colloch's N., Mornon J. P., Loyaux D., Ferrara P. Modification of a reactive cysteine explains differences between rasburicase and Uricozyme®, a natural Aspergillus flavus uricase. Biotechnol. Appl. Biochem. 2002; 36: 21–31, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Back J. F., Oakenful D., Smith M. B. Increased thermal stability of proteins in the presence of sugars and polyols. Biochemistry 1979; 18: 5191–5196, [PUBMED], [INFOTRIEVE]
  • Izutsu K. L., Yoshioka S., Terao T. Decrease protein‐stabilizing effects of cryoprotectants due to crystallization. Pharm. Res. 1993; 10–8: 1232–1237, [CROSSREF]
  • Izutsu K. L., Yoshioka S., Terao T. Effect of mannitol crystallinity on the stabilization of enzymes during freeze‐drying. Chem. Pharm. Bull. 1994; 42(1)5–8, [PUBMED], [INFOTRIEVE], [CSA]
  • Pyne A., Chatterjee K., Suryanarayanan R. Solute crystallization in mannitol‐glycine systems—imlications on protein stabilization in freeze‐dried formulations. J. Pharm. Sci. Nov, 2003; 11: 2272–2283, [CROSSREF]
  • Chang B. S., Randall C. S. Use of subambient thermal analysis to optimize protein lyophilization. Cryobiology 1992; 29: 632, [CROSSREF]
  • Franks F. Freeze‐drying from empiricism to predictability. Cryo‐lett. 1990; 11: 93–110
  • Ediger M. D., Angell C. A., Nagel S. R. Supercooled liquids and glasses. J. Phys. Chem. 1996; 100: 13200–13212, [CROSSREF]
  • Guo Y., Byrn S., Zographi G. Physical characteristics and chemical degradation of amorphous Quinapril hydrochloride. J. Pharm. Sci. 2000; 89(1)128–143, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Scherer G. W. Theory of relaxation. J. Non‐Cryst. Solids 1990; 123: 75–89, [CROSSREF]
  • Kim A. L., Akers M. J., Nail S. L. The physical state of mannitol after freeze‐drying: effects of mannitol concentration, freezing rate, and a non‐crystallizing cosolute. J. Pharm. Sci. 1998; 87: 931–935, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sharma V. K., Kalonia D. S. Effect of vacuum drying on protein‐mannitol interactions: the physical state of mannitol and protein structur in the dried state. AAPS PharmSciTech 2004; 5(1)1–11, Art 10 [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.